Prevalence of NAFLD in T2DM Patients
Not Applicable
Active, not recruiting
- Conditions
- Type 2 DiabetesFatty Liver, NonalcoholicT2DNAFLD
- Interventions
- Diagnostic Test: FibroScan
- Registration Number
- NCT06445335
- Lead Sponsor
- Ziekenhuis Oost-Limburg
- Brief Summary
To determine the prevalence of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus (T2DM).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 385
Inclusion Criteria
- ≥ 18 years of age
- Having type 2 diabetes mellitus (T2DM)
- Written informed consent obtained
Exclusion Criteria
- Excessive alcohol use
- Exclusion of other causes of liver disease and secondary causes of steatosis
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description FibroScan FibroScan -
- Primary Outcome Measures
Name Time Method Prevalence of non-alcoholic fatty liver disease (NAFLD) in type 2 diabetes mellitus (T2DM) patients Baseline To determine the prevalence of non-alcoholic fatty liver disease (NAFLD) in type 2 diabetes mellitus (T2DM) patients followed at the department of Endocrinology in Ziekenhuis Oost-Limburg (ZOL), Genk, Belgium by means of FibroScan measurements.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Ziekenhuis Oost-Limburg
🇧🇪Genk, Limburg, Belgium